Back to List View Graph View

Antiretroviral therapy

Antiretroviral therapy (art) is the standard treatment for human immunodeficiency virus infection: combinations of drugs that block distinct stages of the viral life cycle.

Where the papers sit

11 papers from the last 6 months study antiretroviral therapy directly · updated from PubMed 16 Nov 2026

  • HIV Care Retention and Adherence

    HIV programs are shifting toward sustained retention through multi-month dispensing, adherence counseling, and closer attention to barriers after ART initiation. Loss to follow-up remains concentrated around pregnancy, health-system access, and other social pressures. Adherence is also being tracked during bedaquiline treatment for multidrug-resistant tuberculosis. Pegylated interferon-α studies extend the agenda toward HIV reservoir clearance, but this remains investigational rather than established care.

    5 papers · 45.5%

  • HIV Immune Recovery

    HIV treatment outcomes are linked to CD4+ T-cell dysfunction, cellular exhaustion, and persistent viral reservoirs. Cerebrospinal-fluid HIV escape appears as a complication during cryptococcal meningitis, while nonresponders show disturbed CD4+ T-cell profiles. Mathematical models add cure-rate and transmission perspectives rather than a tested clinical intervention. The cluster shares an HIV persistence and immune-recovery focus but shows no single research direction.

    3 papers · 27.3%

  • Digital HIV Adherence Support

    Digital support is moving toward culturally tailored, just-in-time interventions for people living with HIV. Geofencing and iOS or Android apps are being adapted for adolescents, young adults, and people affected by violence. Alcohol use and tobacco smoking recur as behavioral barriers to antiretroviral adherence, motivating more personalized support. Engagement and real-world effectiveness remain open questions.

    3 papers · 27.3%

PARADIGM SHIFT

Systemic viral suppression on antiretroviral therapy does not ensure immune reconstitution or viral control in other compartments

The study of people with HIV who were immunological non-responders despite treatment 42853340Oct and the case of cryptococcal meningitis with cerebrospinal-fluid HIV escape during continuous treatment 42749340Sep both challenge the assumption that antiretroviral therapy’s systemic viral suppression reliably produces complete biological control. The first found persistent CD4+ T-cell disturbance and elevated exhaustion-related genes despite viral suppression, while the second found detectable cerebrospinal-fluid HIV RNA despite suppressed serum virus and stable CD4-cell counts. Together, they shift the account from ART as uniformly controlling HIV and restoring immunity to ART as control that may fail to produce immune recovery or may leave compartment-specific viral activity requiring additional investigation and, in the CNS case, treatment intensification.

Papers

The 11 papers from the last 6 months that study antiretroviral therapy directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

HIV Care Retention and Adherence (5)
  1. Temporal proximity to counseling is associated with longitudinal bedaquiline and antiretroviral therapy adherence in multidrug-resistant tuberculosis and HIV treatment. PloS one · 5 Oct 2026 PMID 42832504
  2. What went wrong? A qualitative exploration of the determinants of poor adherence to antiretroviral therapy and retention in care among pregnant and postpartum women in the Uganda WiseMama trial. Global public health · 24 Sept 2026 PMID 42779011
  3. Incidence and predictors of loss to follow-up after ART initiation at public health facilities in Sierra Leone (2020-2024): a retrospective cohort study. BMJ open · 24 Jul 2026 PMID 42498473
  4. Effectiveness of pegylated interferon-α combined with antiretroviral therapy on HIV reservoir clearance in acute HIV infection: study protocol for a randomised controlled trial at a tertiary infectious disease hospital in Beijing, China. BMJ open · 2 Jul 2026 PMID 42392622
  5. HIV Care Retention and Cost Analysis in Multi-Month ART Dispensing: A Randomized Controlled Trial in China. Journal of the International AIDS Society · 24 Jun 2026 PMID 42339560
HIV Immune Recovery (3)
  1. Upregulation of cellular exhaustion-related genes and CD4 + T cell disturbances in immunological non-responders on antiretroviral therapy. Immunologic research · 9 Oct 2026 PMID 42853340
  2. Cryptococcal meningitis with cerebrospinal fluid human immunodeficiency virus escape presenting as transient diplopia and areflexia. BMJ case reports · 16 Sept 2026 PMID 42749340
  3. A modified HIV model with Beddington-DeAngelis incidence and cure rate. Scientific reports · 26 May 2026 PMID 42191796
Digital HIV Adherence Support (3)
  1. A Geospatially Customizable Culturally Tailored Just-in-Time Adaptive Intervention for Violence-Affected People Living With HIV: Mixed Methods Acceptability, Feasibility, and User Experience Study. JMIR human factors · 26 Jun 2026 PMID 42360924
  2. Alcohol consumption and tobacco smoking associated with decreased antiretroviral therapy adherence among people living with HIV in Zambia: Evidence from a 2023 national NCDs/ HIV survey. PloS one · 12 Jun 2026 PMID 42284276
  3. Adapting a medication adherence app for adolescents and young adults in Makurdi, Benue State: The Lu Dedoo Project. PloS one · 29 May 2026 PMID 42213746

By study type

Clinical trials (3)
  1. Temporal proximity to counseling is associated with longitudinal bedaquiline and antiretroviral therapy adherence in multidrug-resistant tuberculosis and HIV treatment. PloS one · 5 Oct 2026 PMID 42832504
  2. Effectiveness of pegylated interferon-α combined with antiretroviral therapy on HIV reservoir clearance in acute HIV infection: study protocol for a randomised controlled trial at a tertiary infectious disease hospital in Beijing, China. BMJ open · 2 Jul 2026 PMID 42392622
  3. HIV Care Retention and Cost Analysis in Multi-Month ART Dispensing: A Randomized Controlled Trial in China. Journal of the International AIDS Society · 24 Jun 2026 PMID 42339560
Observational studies and case reports (3)
  1. Cryptococcal meningitis with cerebrospinal fluid human immunodeficiency virus escape presenting as transient diplopia and areflexia. BMJ case reports · 16 Sept 2026 PMID 42749340
  2. Incidence and predictors of loss to follow-up after ART initiation at public health facilities in Sierra Leone (2020-2024): a retrospective cohort study. BMJ open · 24 Jul 2026 PMID 42498473
  3. Alcohol consumption and tobacco smoking associated with decreased antiretroviral therapy adherence among people living with HIV in Zambia: Evidence from a 2023 national NCDs/ HIV survey. PloS one · 12 Jun 2026 PMID 42284276
Human data, design not indexed (5)
  1. Upregulation of cellular exhaustion-related genes and CD4 + T cell disturbances in immunological non-responders on antiretroviral therapy. Immunologic research · 9 Oct 2026 PMID 42853340
  2. What went wrong? A qualitative exploration of the determinants of poor adherence to antiretroviral therapy and retention in care among pregnant and postpartum women in the Uganda WiseMama trial. Global public health · 24 Sept 2026 PMID 42779011
  3. A Geospatially Customizable Culturally Tailored Just-in-Time Adaptive Intervention for Violence-Affected People Living With HIV: Mixed Methods Acceptability, Feasibility, and User Experience Study. JMIR human factors · 26 Jun 2026 PMID 42360924
  4. Adapting a medication adherence app for adolescents and young adults in Makurdi, Benue State: The Lu Dedoo Project. PloS one · 29 May 2026 PMID 42213746
  5. A modified HIV model with Beddington-DeAngelis incidence and cure rate. Scientific reports · 26 May 2026 PMID 42191796